patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Announces Proposed Public Offering of Common Stock and Warrants to Pur

tomorrow is Thursday here. I wished they announced how many shares and warrants as well as when they were going to release them. the negative could be a major dilution of the shareholders principal thus I see a fall in the stock price.

Share
New Message
Please login to post a reply